Zhiyu Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhiyu Peng has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Jiandong Mei
Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China
2 shared publications - Lin-Chuan Liang
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Panjiayuan, Nanli 17, Beijing 100021, China
2 shared publications - Zhengyong Li
Department of Burn and Plastic Surgery, West China Hospital, Sichuan University, Chengdu, China
2 shared publications Bin Zhang
Department of Orthopedics Surgery, West China Hospital, Sichuan University, 37 Guoxue Lane, Chengdu, 610041, Sichuan, China
1 shared publicationChangchun Zhou
National Engineering Research Center for Biomaterials , Sichuan University , 610064 , Chengdu , China
1 shared publication- Changchun Zhou
National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu, 610064, China
1 shared publication
Latest Publications
- Open Access
- 8 August 2025
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 58 (8) , 1109-1119
Postoperative venous thromboembolism risk following lung cancer surgery: a systematic review and meta-analysis
Venous thromboembolism (VTE) remains a major contributor to postoperative morbidity and mortality in patients undergoing lung cancer surgery. This study aims to identify perioperative risk factors associated with VTE development following such procedures. We performed an exhaustive search of PUBMED and EMBASE from inception to November 1, 2023, using terms related to VTE following lung cancer surgery. A random-effects meta-analysis was performed to calculate the pooled incidence and odds ratios (ORs) for risk factors. Of 3,576 screened studies, 13 met eligibility criteria for qualitative synthesis, and 11 studies (53,382 patients) were included in the meta-analysis. The pooled incidence of postoperative VTE was 1.82% (971 cases). Significant risk factors included advanced age (standardized mean difference [SMD] 0.43, 95% CI 0.22-0.63; I2 = 59.9%), prolonged surgical duration (SMD 0.58, 95% CI 0.24-0.92; I2 = 81.2%), open thoracotomy (OR 1.77, 95% CI 1.50-2.09; I2 = 19.9%), TNM stage > 1 (OR = 1.81, 95% CI 1.53-2.13; I2 = 39.8%), adenocarcinoma histology (OR = 1.29, 95% CI 1.08-1.53; I2 = 1.2%), and major lung resection (OR = 1.51, 95% CI 1.24-1.83; I2 = 0.0%). This study highlights key modifiable and non-modifiable risk factors for postoperative VTE in lung cancer surgery patients. These findings support individualized risk stratification and targeted thromboprophylaxis strategies to improve clinical outcomes.
- 8 August 2025
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 58 (8) , 1109-1119
Open AccessPostoperative venous thromboembolism risk following lung cancer surgery: a systematic review and meta-analysis
Venous thromboembolism (VTE) remains a major contributor to postoperative morbidity and mortality in patients undergoing lung cancer surgery. This study aims to identify perioperative risk factors associated with VTE development following such procedures. We performed an exhaustive search of PUBMED and EMBASE from inception to November 1, 2023, using terms related to VTE following lung cancer surgery. A random-effects meta-analysis was performed to calculate the pooled incidence and odds ratios (ORs) for risk factors. Of 3,576 screened studies, 13 met eligibility criteria for qualitative synthesis, and 11 studies (53,382 patients) were included in the meta-analysis. The pooled incidence of postoperative VTE was 1.82% (971 cases). Significant risk factors included advanced age (standardized mean difference [SMD] 0.43, 95% CI 0.22-0.63; I2 = 59.9%), prolonged surgical duration (SMD 0.58, 95% CI 0.24-0.92; I2 = 81.2%), open thoracotomy (OR 1.77, 95% CI 1.50-2.09; I2 = 19.9%), TNM stage > 1 (OR = 1.81, 95% CI 1.53-2.13; I2 = 39.8%), adenocarcinoma histology (OR = 1.29, 95% CI 1.08-1.53; I2 = 1.2%), and major lung resection (OR = 1.51, 95% CI 1.24-1.83; I2 = 0.0%). This study highlights key modifiable and non-modifiable risk factors for postoperative VTE in lung cancer surgery patients. These findings support individualized risk stratification and targeted thromboprophylaxis strategies to improve clinical outcomes.
- Open Access
- 4 March 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (4) , 2433-2434
A commentary on “impact of sarcopenia on outcomes in surgical patients: A systematic review and meta-analysis”
An abstract is unavailable. This article is available as a PDF only.
- 4 March 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (4) , 2433-2434
Open AccessA commentary on “impact of sarcopenia on outcomes in surgical patients: A systematic review and meta-analysis”
An abstract is unavailable. This article is available as a PDF only.
- Open Access
- 4 December 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (3) , 1802-1803
A commentary on ‘The number of metastatic lymph nodes is more predictive of prognosis than location-based N stage for non-small cell lung cancer: a retrospective cohort study’
An abstract is unavailable. This article is available as a PDF only.
- 4 December 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (3) , 1802-1803
Open AccessA commentary on ‘The number of metastatic lymph nodes is more predictive of prognosis than location-based N stage for non-small cell lung cancer: a retrospective cohort study’
An abstract is unavailable. This article is available as a PDF only.
- Open Access
Review of Plastic Surgery Biomaterials and Current Progress in Their 3D Manufacturing Technology
Plastic surgery is a broad field, including maxillofacial surgery, skin flaps and grafts, liposuction and body contouring, breast surgery, and facial cosmetic procedures. Due to the requirements of plastic surgery for the biological safety of materials, biomaterials are widely used because of its superior biocompatibility and biodegradability. Currently, there are many kinds of biomaterials clinically used in plastic surgery and their applications are diverse. Moreover, with the rise of three-dimensional printing technology in recent years, the macroscopically more precise and personalized bio-scaffolding materials with microporous structure have made good progress, which is thought to bring new development to biomaterials. Therefore, in this paper, we reviewed the plastic surgery biomaterials and current progress in their 3D manufacturing technology.
Open AccessReview of Plastic Surgery Biomaterials and Current Progress in Their 3D Manufacturing Technology
Plastic surgery is a broad field, including maxillofacial surgery, skin flaps and grafts, liposuction and body contouring, breast surgery, and facial cosmetic procedures. Due to the requirements of plastic surgery for the biological safety of materials, biomaterials are widely used because of its superior biocompatibility and biodegradability. Currently, there are many kinds of biomaterials clinically used in plastic surgery and their applications are diverse. Moreover, with the rise of three-dimensional printing technology in recent years, the macroscopically more precise and personalized bio-scaffolding materials with microporous structure have made good progress, which is thought to bring new development to biomaterials. Therefore, in this paper, we reviewed the plastic surgery biomaterials and current progress in their 3D manufacturing technology.
- Open Access
- 1 January 2020
- Published by Walter de Gruyter GmbH in Nanotechnology Reviews
- Vol. 9 (1) , 385-395
Advances in biomaterials for adipose tissue reconstruction in plastic surgery
Adipose tissue reconstruction is an important technique for soft tissue defects caused by facial plastic surgery and trauma. Adipose tissue reconstruction can be repaired by fat transplantation and biomaterial filling, but there are some problems in fat transplantation, such as second operation and limited resources. The application of advanced artificial biomaterials is a promising strategy. In this paper, injectable biomaterials and three-dimensional (3D) tissue-engineered scaffold materials for adipose tissue reconstruction in plastic surgery are reviewed. Injectable biomaterials include natural biomaterials and artificial biomaterials, which generally have problems such as high absorptivity of fillers, repeated injection, and rejection. In recent years, the technology of new 3D tissue-engineering scaffold materials with adipose-derived stem cells (ADSCs) and porous scaffold as the core has made good progress in fat reconstruction, which is expected to solve the current problem of clinical adipose tissue reconstruction, and various biomaterials preparation technology and transformation research also provide the basis for clinical transformation of fat tissue reconstruction.
- 1 January 2020
- Published by Walter de Gruyter GmbH in Nanotechnology Reviews
- Vol. 9 (1) , 385-395
Open AccessAdvances in biomaterials for adipose tissue reconstruction in plastic surgery
Adipose tissue reconstruction is an important technique for soft tissue defects caused by facial plastic surgery and trauma. Adipose tissue reconstruction can be repaired by fat transplantation and biomaterial filling, but there are some problems in fat transplantation, such as second operation and limited resources. The application of advanced artificial biomaterials is a promising strategy. In this paper, injectable biomaterials and three-dimensional (3D) tissue-engineered scaffold materials for adipose tissue reconstruction in plastic surgery are reviewed. Injectable biomaterials include natural biomaterials and artificial biomaterials, which generally have problems such as high absorptivity of fillers, repeated injection, and rejection. In recent years, the technology of new 3D tissue-engineering scaffold materials with adipose-derived stem cells (ADSCs) and porous scaffold as the core has made good progress in fat reconstruction, which is expected to solve the current problem of clinical adipose tissue reconstruction, and various biomaterials preparation technology and transformation research also provide the basis for clinical transformation of fat tissue reconstruction.
- 26 November 2019
- Published by Springer Nature in International Orthopaedics
- Vol. 44 (2) , 309-317
Learning curve and clinical outcomes of percutaneous endoscopic transforaminal decompression for lumbar spinal stenosis
To define and analyze the learning curve of percutaneous endoscopic transforaminal decompression (PETD) for lumbar spinal stenosis (LSS).
- 26 November 2019
- Published by Springer Nature in International Orthopaedics
- Vol. 44 (2) , 309-317
Learning curve and clinical outcomes of percutaneous endoscopic transforaminal decompression for lumbar spinal stenosis
To define and analyze the learning curve of percutaneous endoscopic transforaminal decompression (PETD) for lumbar spinal stenosis (LSS).